University of Miami Sylvester Comprehensive Cancer Center

 

University of Miami Sylvester Comprehensive Cancer Center
A

Evaluating Zanubrutinib + Tafasitamab in MCL

By University of Miami Sylvester Comprehensive Cancer Center FEATURING Alvaro Alencar
By University of Miami Sylvester Comprehensive Cancer Center FEATURING Alvaro Alencar
25 views
May 7, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip

Featured Video

19:25
Pfizer Hematology

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

Feat. A. Ip
Lymphoma
22:04

MZL: Current Management and Emerging Therapeutics

University of Miami Sylvester Comprehensive Cancer Center

I. Lossos

52 views
08:42

Optimizing Early Stage HL Treatment: Eliminating or Replacing Radiat…

University of Miami Sylvester Comprehensive Cancer Center

C. Moskowitz

29 views
10:52

Current Treatment of 1L Hodgkin Lymphoma

University of Miami Sylvester Comprehensive Cancer Center

C. Moskowitz

485 views
07:41

Using BTKis in MCL Today

University of Miami Sylvester Comprehensive Cancer Center

A. Alencar

66 views
09:10

Evaluating Zanubrutinib + Tafasitamab in MCL

University of Miami Sylvester Comprehensive Cancer Center

A. Alencar

25 views
27:01

Hodgkin Lymphoma - Metabolic Tumor Volume as Prognostic Factor, Role…

University of Miami Sylvester Comprehensive Cancer Center

C. Moskowitz

268 views